Hardware Podcasts

What is MedTech Lifecycle Excellence?

Global Medical Device Podcast · 5 Jan 2023 · 45m · Episode 297

What this episode covers

Jon Bergsteinsson, co-founder of SMART-TRIAL by Greenlight Guru, explains why the MedTech industry struggles with generic compliance tools designed for pharmaceuticals and advocates for MedTech Lifecycle Excellence. He argues that because 95% of MedTech companies are small-to-medium enterprises, they need integrated digital solutions that align design, clinical, and regulatory workflows rather than siloed, Excel-based processes. Bergsteinsson highlights the importance of community-driven knowledge sharing and breaking down competitive barriers to accelerate the delivery of safe devices to market.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Greenlight Guru, Johnson and Johnson, Philips, ABB, Uber, DHL
Products
SMART-TRIAL
Also
MDR, IVDR, FDA

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 31m

    178 - CAPA Face-Off: Pharma vs. MedTech – Key Differences You Need to Know

    Aaron Snyder, founder of Quality Systems Explained and former VP of QA at Allotex, explains the regulatory and operational differences in CAPA (Corrective and Preventive Action) between pharmaceutical and MedTech industries. He highlights that while Pharma regulations (21 CFR 210/211) focus on 'deviations' and MedTech (21 CFR 820) mandates 'corrective and preventive action,' effective systems in both sectors perform similar root cause investigations. Snyder emphasizes that CAPA systems fail without strong management support, leading to 'birthday' CAPAs that remain open for years, and advocates for structured root cause tools like Ishikawa diagrams over manipulated 5 Whys.

    Quality & yieldCertification & compliance
    8 chapters

  • Let's Combinate · 8m

    244 - 5 Critical Quality Differences Between Drugs and Devices

    Subhi Saadeh, a consultant specializing in drug-device combination products, explains five critical quality differences between pharmaceuticals and medical devices. He contrasts the drug industry's focus on consistent manufacturing of clinically proven products (ICH Q8/Q9) with the device industry's emphasis on design robustness and user needs (ISO 13485/14971). The discussion covers divergent approaches to risk management, regulatory submission evidence, and lifecycle change control, urging teams to intentionally integrate these systems rather than forcing one onto the other.

    Medical & health devicesCertification & compliance
    1 chapters

  • Let's Combinate · 32m

    107 - Distilling Decades of MedTech Data, Generative AI, and Doing Without Tribal Knowledge with Michelle Wu

    Michelle Wu, CEO and Founder of NyquistData, explains how her company uses generative AI to distill decades of MedTech data, removing the 'tribal knowledge' barrier for quality and regulatory professionals. She details the distinction between pre-trained models and fine-tuned algorithms, emphasizing that Nyquist’s data is validated and specific to FDA and global medical device regulations, unlike generic models like OpenAI. Wu discusses the challenge of changing organizational culture and overcoming skepticism in life sciences, highlighting features like the 'Device Explorer' and 'Data Writer' that democratize access to complex regulatory insights.

    AI & machine learningQuality & yield
    10 chapters

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

    Quality & yieldStarting a product company
    8 chapters

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

    Certification & complianceQuality & yield
    11 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.